These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2883201)

  • 1. Schizophrenic thinking and neuroleptic dosage.
    Puente AE; Andersson C
    J Clin Psychol; 1987 Mar; 43(2):189-97. PubMed ID: 2883201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of clinical status of schizophrenic patients by the WAIS comprehension subtest.
    Bigelow LB; Donnelly EP; Torrey EF; Lee CA
    J Clin Psychiatry; 1979 Jun; 40(6):258-61. PubMed ID: 36371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visual and motor functions in schizophrenic patients].
    Del Vecchio S; Gargiulo PA
    Acta Psiquiatr Psicol Am Lat; 1992 Dec; 38(4):317-22. PubMed ID: 1364126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study].
    Schmidt LG; Siemetzki H
    Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia].
    Lisoprawski A
    Sem Hop; 1983 Jun; 59(25):1925-7. PubMed ID: 6136096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia.
    Hutton SB; Crawford TJ; Gibbins H; Cuthbert I; Barnes TR; Kennard C; Joyce EM
    Psychopharmacology (Berl); 2001 Sep; 157(3):284-91. PubMed ID: 11605084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
    Himelhoch S; Taylor SF; Goldman RS; Tandon R
    Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
    [No Abstract]   [Full Text] [Related]  

  • 10. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
    Nagase Y; Okubo Y; Toru M
    Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptic treatment and neurological soft signs in schizophrenic patients].
    Mechri A; Slama H; Chebel S; Mandhouj O; Gaha L
    Therapie; 2007; 62(5):449-53. PubMed ID: 18206107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Configuration frequency analysis. XI. Strategies of symptom configuration comparison before and after therapy].
    Lienert GA; Straube E
    Z Klin Psychol Psychother; 1980; 28(2):110-23. PubMed ID: 6108653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR; Shea PA; Hendrie HC
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cortical atrophy in MRI, mental status and neuroleptic treatment effect in schizophrenia].
    Jarema M; Choma M; Kozłowski P; Poniatowska R; Krawczyk R
    Psychiatr Pol; 1997; 31(5):547-57. PubMed ID: 9547181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic nervous system differences as predictors of short-term outcome in schizophrenics.
    Straube ER; Schied HW; Rein W; Breyer-Pfaff U
    Pharmacopsychiatry; 1987 May; 20(3):105-10. PubMed ID: 2885864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W; Kilian R; Toumi M; Angermeyer MC
    Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.